Early Combined Intervention After Traumatic Injury

创伤后早期联合干预

基本信息

  • 批准号:
    8031462
  • 负责人:
  • 金额:
    $ 10.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Each year in the United States approximately 2.5 million individuals are hospitalized after sustaining traumatic physical injuries. Within 48 hours after the September 11th 2001 attack, 1,103 injured victims were triaged through 5 New York City acute care centers. Injured patients are at high risk for developing posttraumatic stress disorder (PTSD) and related comorbidities. High quality interventions remain to be developed for injured trauma survivors who begin their care episode as surgical inpatients and are followed up through primary care outpatient visits and community rehabilitation. The goal of this randomized clinical trial is to test the effectiveness of an early intervention that combines evidence-based psychotherapeutic and psychopharmacological treatments with case management. The early combined intervention is hypothesized to reduce PTSD symptoms, improve post-injury functioning, diminish alcohol consumption, and prevent new injuries. Over a 3 year period, 420 injured trauma survivors ages 18 or older will be recruited from the inpatient trauma surgery service of the University of Washington's Harborview Medical Center and randomized to receive the combined intervention or care as usual. Intervention patients will receive care from a trauma center based mental health team that includes 2 front-line RN interventionists as well as supervising MD/PhD consultants. The case management intervention component engages patients in posttraumatic care and also provides continuity of care by linking treatment across surgical, primary care, and community service delivery sectors. The evidence-based component of the combined intervention includes cognitive behavioral therapy and medications targeting PTSD and motivational interviewing targeting alcohol consumption. Evidence-based interventions will be tailored to patients' preferences and will be delivered at critical junctures after the injury in a stepped fashion. 1, 3, 6, 9, and 12 months after the acute care inpatient admission, the 2 groups will be compared on measures of PTSD, functional impairment, alcohol consumption, new injury hospitalizations, and costs. The investigation includes a national advisory committee that will integrate study findings into ongoing policy discussions surrounding the adoption of sustainable acute mental health services for diverse injured survivors of individual and mass trauma.
描述(由申请人提供):在美国,每年约有 250 万人因遭受身体创伤而住院治疗。 2001 年 9 月 11 日袭击事件发生后 48 小时内,纽约市 5 个急救中心对 1,103 名伤者进行了分类。受伤患者患创伤后应激障碍 (PTSD) 和相关合并症的风险很高。对于受伤的创伤幸存者来说,高质量的干预措施仍有待开发,他们从手术住院患者开始接受护理,并通过初级保健门诊就诊和社区康复进行随访。这项随机临床试验的目的是测试将循证心理治疗和精神药理学治疗与病例管理相结合的早期干预的有效性。假设早期联合干预可以减少创伤后应激障碍症状、改善受伤后功能、减少饮酒并预防新的伤害。在 3 年的时间内,将从华盛顿大学 Harbourview 医疗中心的住院创伤外科服务中招募 420 名 18 岁或以上的受伤创伤幸存者,并随机接受照常的联合干预或护理。干预患者将接受创伤中心心理健康团队的护理,该团队包括 2 名一线 RN 干预师以及医学博士/博士指导顾问。病例管理干预部分让患者参与创伤后护理,并通过将外科、初级护理和社区服务提供部门的治疗联系起来,提供护理的连续性。联合干预的循证部分包括认知行为疗法和针对创伤后应激障碍的药物治疗以及针对饮酒的动机访谈。基于证据的干预措施将根据患者的喜好量身定制,并将在受伤后的关键时刻逐步实施。急性护理住院患者入院后 1、3、6、9 和 12 个月,将比较两组的 PTSD、功能障碍、饮酒量、新伤住院治疗和费用。该调查包括一个国家咨询委员会,该委员会将把研究结果纳入正在进行的政策讨论中,围绕为个人和大规模创伤的各种受伤幸存者提供可持续的急性心理健康服务。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Using target population specification, effect size, and reach to estimate and compare the population impact of two PTSD preventive interventions.
使用目标人群规格、效应大小和范围来估计和比较两种 PTSD 预防干预措施的人群影响。
  • DOI:
    10.1521/psyc.2009.72.4.346
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Zatzick,DouglasF;Koepsell,Thomas;Rivara,FrederickP
  • 通讯作者:
    Rivara,FrederickP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS F ZATZICK其他文献

DOUGLAS F ZATZICK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS F ZATZICK', 18)}}的其他基金

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
与政策相关的美国创伤护理系统针对创伤后应激障碍 (PTSD) 和合并症的实用试验
  • 批准号:
    9178219
  • 财政年份:
    2014
  • 资助金额:
    $ 10.17万
  • 项目类别:
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
与政策相关的美国创伤护理系统针对创伤后应激障碍 (PTSD) 和合并症的实用试验
  • 批准号:
    9126605
  • 财政年份:
    2014
  • 资助金额:
    $ 10.17万
  • 项目类别:
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
与政策相关的美国创伤护理系统针对创伤后应激障碍 (PTSD) 和合并症的实用试验
  • 批准号:
    8776024
  • 财政年份:
    2014
  • 资助金额:
    $ 10.17万
  • 项目类别:
Research, Mentoring & Dissemination for PTSD Intervention in Acute Care Settings
研究、指导
  • 批准号:
    8084071
  • 财政年份:
    2010
  • 资助金额:
    $ 10.17万
  • 项目类别:
Research, Mentoring & Dissemination for PTSD Intervention in Acute Care Settings
研究、指导
  • 批准号:
    7893508
  • 财政年份:
    2010
  • 资助金额:
    $ 10.17万
  • 项目类别:
Research, Mentoring & Dissemination for PTSD Intervention in Acute Care Settings
研究、指导
  • 批准号:
    8670770
  • 财政年份:
    2010
  • 资助金额:
    $ 10.17万
  • 项目类别:
Research, Mentoring & Dissemination for PTSD Intervention in Acute Care Settings
研究、指导
  • 批准号:
    8307393
  • 财政年份:
    2010
  • 资助金额:
    $ 10.17万
  • 项目类别:
Research, Mentoring & Dissemination for PTSD Intervention in Acute Care Settings
研究、指导
  • 批准号:
    8463248
  • 财政年份:
    2010
  • 资助金额:
    $ 10.17万
  • 项目类别:
Disseminating Organizational SBI Services (DO-SBIS) at Trauma Centers
在创伤中心传播组织 SBI 服务 (DO-SBIS)
  • 批准号:
    7319475
  • 财政年份:
    2007
  • 资助金额:
    $ 10.17万
  • 项目类别:
Disseminating Organizational SBI Services (DO-SBIS) at Trauma Centers
在创伤中心传播组织 SBI 服务 (DO-SBIS)
  • 批准号:
    7666224
  • 财政年份:
    2007
  • 资助金额:
    $ 10.17万
  • 项目类别:

相似海外基金

抗酸化能を高めたN-acetylcysteineによる老視と白内障抑制機構の解明
阐明具有增强抗氧化能力的N-乙酰半胱氨酸抑制老花眼和白内障的机制
  • 批准号:
    23K15945
  • 财政年份:
    2023
  • 资助金额:
    $ 10.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10758985
  • 财政年份:
    2023
  • 资助金额:
    $ 10.17万
  • 项目类别:
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10619173
  • 财政年份:
    2022
  • 资助金额:
    $ 10.17万
  • 项目类别:
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10517287
  • 财政年份:
    2021
  • 资助金额:
    $ 10.17万
  • 项目类别:
A randomised controlled trial of N-acetylcysteine for the treatment of alcohol use disorder
N-乙酰半胱氨酸治疗酒精使用障碍的随机对照试验
  • 批准号:
    nhmrc : 2001375
  • 财政年份:
    2021
  • 资助金额:
    $ 10.17万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
High dose acetaminophen with n-acetylcysteine rescue as a novel STAT3 inhibitor with anti-cancer stem cell properties
高剂量对乙酰氨基酚与 n-乙酰半胱氨酸救援作为具有抗癌干细胞特性的新型 STAT3 抑制剂
  • 批准号:
    10368472
  • 财政年份:
    2021
  • 资助金额:
    $ 10.17万
  • 项目类别:
N-acetylcysteineの骨治癒促進効果の検討
N-乙酰半胱氨酸促进骨愈合作用的考察
  • 批准号:
    20H01118
  • 财政年份:
    2020
  • 资助金额:
    $ 10.17万
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
Targeting the neurobiology of restricted and repetitive behaviors in children with autism using N-acetylcysteine
使用 N-乙酰半胱氨酸针对自闭症儿童限制性和重复性行为的神经生物学
  • 批准号:
    10221760
  • 财政年份:
    2020
  • 资助金额:
    $ 10.17万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10188441
  • 财政年份:
    2020
  • 资助金额:
    $ 10.17万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10462621
  • 财政年份:
    2020
  • 资助金额:
    $ 10.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了